All publications

Export 146 results:
Author Title Type [ Year(Asc)]
2017
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin C, Nelson M, Winston A et al..  2017.  An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother.
Collins IJ, Foster C, Tostevin A, Tookey P, Riordan A, Dunn D, Gibb DM, Judd A.  2017.  Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clin Infect Dis. Epub ahead of print
2016
El-Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie NE, Pozniak A, Tostevin A, Pillay D, Dunn D et al..  2016.  HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12)
Ragonnet-Cronin M, Shilaih M, Gunthard H.F, Hodcroft EB, Boni J, Fearnhill E, Dunn D, Yerly S, Klimait T, Aubert V et al..  2016.  A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland. Sci Rep. 6
Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, Asboe D, Pozniak A, Churchill D, Geretti AM et al..  2016.  Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom. HIV Med.
De Luca A., Flandre P., Dunn D, Zazzi M, Wensing A., Santoro MM, Gunthard H.F, Wittkop L., Kordossis T., Garcia F. et al..  2016.  Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 71:1352-60.
Jose S., Quinn K., Dunn D, Cox A., Sabin C, Fidler S.  2016.  Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation. HIV Med. 17:368-72.
Ragonnet-Cronin M, Lycett SJ, Hodcroft EB, Hué S, Fearnhill E, Brown A.E, Delpech V, Dunn D, Leigh Brown A.J.  2016.  Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters. J Infect Dis. 213:1410-8.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn D, UK HIV Drug Resistance Database et al..  2016.  No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.
TenoRes Study Group.  2016.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis.
Antiretroviral Therapy Cohort Collaboration(ART-CC), Canadian Observational Cohort Collaboration(CANOC), UK Collaborative HIV Cohort Study(UK CHIC), Collaboration of Observational HIV Epidemiological Research in Europe(COHERE).  2016.  Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. AIDS. 30(3)
Geretti A M, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C, Dunn D et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. International HIV Drug Resistance Workshop 2016.
Geretti A M, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C, Dunn D et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. International HIV Drug Resistance Workshop 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
Hué S, Villanueva RMucio, Tostevin A, Delpech V, Pozniak A, Ashton L, Pillay D, Goldstein R, UK HIV Drug Resistance Database.  2016.  Probabalistic Estimation of HIV-1 Subtype B Transmission Rates from Viral Phylogenies. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
Le Vu S, Ratmann O, Delpech V, Brown A.E, Gill N, Tostevin A, Fraser C, Volz E.  2016.  Characterising HIV transmission risk factors using genetic source attribution and phylogenetic clustering. HIV Dynamics and Evolution Meeting 2016.
2015
Mbisa JL, Fearnhill E, Dunn D, Pillay D, Asboe D, Cane P A.  2015.  Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clin Infect Dis. 61:829-36.
Mourad R, Chevennet F, Dunn D, Fearnhill E, Delpech V, Asboe D, Gascuel O, Hué S.  2015.  A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK. AIDS. 29:1917-25.
Tostevin A, White E, Croxford S, Delpech V, Williams I, Dunn D, UK HIV Drug Resistance Database.  2015.  Trends in transmitted drug resistance to HIV-1 in the UK since 2010. British HIV Association Conference (BHIVA) 2015.